Literature DB >> 25908460

Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.

Shadi Yaghi1, Yeseon P Moon2, Consuelo Mora-McLaughlin2, Joshua Z Willey2, Ken Cheung2, Marco R Di Tullio2, Shunichi Homma2, Hooman Kamel2, Ralph L Sacco2, Mitchell S V Elkind2.   

Abstract

BACKGROUND AND
PURPOSE: Although left atrial enlargement (LAE) increases incident stroke risk, the association with recurrent stroke is less clear. Our aim was to determine the association of LAE with recurrent stroke most likely related to embolism (cryptogenic and cardioembolic) and all ischemic stroke recurrences.
METHODS: We followed 655 first ischemic stroke patients in the Northern Manhattan Stroke Study for ≤5 years. LA size from 2D echocardiography was categorized as normal LAE (52.7%), mild LAE (31.6%), and moderate-severe LAE (15.7%). We used Cox proportional hazard models to calculate the hazard ratios and 95% confidence intervals for the association of LA size and LAE with recurrent cryptogenic/cardioembolic and total recurrent ischemic stroke.
RESULTS: LA size was available in 529 (81%) patients. Mean age at enrollment was 69±13 years; 45.8% were male, 54.0% Hispanic, and 18.5% had atrial fibrillation. Over a median of 4 years, there were 65 recurrent ischemic strokes (29 were cardioembolic or cryptogenic). In multivariable models adjusted for confounders, including atrial fibrillation and heart failure, moderate-severe LAE compared with normal LA size was associated with greater risk of recurrent cardioembolic/cryptogenic stroke (adjusted hazard ratio 2.83, 95% confidence interval 1.03-7.81), but not total ischemic stroke (adjusted hazard ratio 1.06, 95% confidence interval, 0.48-2.30). Mild LAE was not associated with recurrent stroke.
CONCLUSION: Moderate to severe LAE was an independent marker of recurrent cardioembolic or cryptogenic stroke in a multiethnic cohort of ischemic stroke patients. Further research is needed to determine whether anticoagulant use may reduce risk of recurrence in ischemic stroke patients with moderate to severe LAE.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  embolism

Mesh:

Year:  2015        PMID: 25908460      PMCID: PMC4442058          DOI: 10.1161/STROKEAHA.115.008711

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

1.  American Society of Echocardiography recommendations for quality echocardiography laboratory operations.

Authors:  Michael H Picard; David Adams; S Michelle Bierig; John M Dent; Pamela S Douglas; Linda D Gillam; Andrew M Keller; David J Malenka; Frederick A Masoudi; Marti McCulloch; Patricia A Pellikka; Priscilla J Peters; Raymond F Stainback; G Monet Strachan; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2011-01       Impact factor: 5.251

2.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

3.  Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.

Authors:  George Ntaios; Vasileios Papavasileiou; Haralambos Milionis; Konstantinos Makaritsis; Efstathios Manios; Konstantinos Spengos; Patrik Michel; Konstantinos Vemmos
Journal:  Stroke       Date:  2014-11-06       Impact factor: 7.914

4.  Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function.

Authors:  A V Mattioli; S Sansoni; G R Lucchi; G Mattioli
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

5.  Influence of left atrial pressure on left atrial appendage flow velocity patterns in patients in sinus rhythm.

Authors:  T Tabata; T Oki; N Fukuda; A Iuchi; K Manabe; Y Kageji; M Sasaki; H Yamada; S Ito
Journal:  J Am Soc Echocardiogr       Date:  1996 Nov-Dec       Impact factor: 5.251

6.  A simple score for predicting paroxysmal atrial fibrillation in acute ischemic stroke.

Authors:  Shuichi Fujii; Kensaku Shibazaki; Kazumi Kimura; Kenichiro Sakai; Junya Aoki
Journal:  J Neurol Sci       Date:  2013-03-19       Impact factor: 3.181

7.  LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study.

Authors:  Cesare Russo; Zhezhen Jin; Rui Liu; Shinichi Iwata; Aylin Tugcu; Mitsuhiro Yoshita; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Charles Decarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  JACC Cardiovasc Imaging       Date:  2013-03

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

10.  Relation between left atrial enlargement and stroke subtypes in acute ischemic stroke patients.

Authors:  Hye-Young Shin; In-Hye Jeong; Chang-Ki Kang; Dong-Jin Shin; Hyeon-Mi Park; Kee-Hyung Park; Young-Hee Sung; Dong-Hoon Shin; Young Noh; Yeong-Bae Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2013-09-30
View more
  66 in total

Review 1.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

Review 2.  Cardioembolic Stroke.

Authors:  Hooman Kamel; Jeff S Healey
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 3.  Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Neurology       Date:  2015-07-17       Impact factor: 9.910

4.  Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpson's method.

Authors:  Laura Kristin Wandelt; Johannes Tammo Kowallick; Andreas Schuster; Rolf Wachter; Thomas Stümpfig; Christina Unterberg-Buchwald; Michael Steinmetz; Christian Oliver Ritter; Joachim Lotz; Wieland Staab
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-18       Impact factor: 2.357

5.  Associations of echocardiographic features with stroke in those without atrial fibrillation.

Authors:  Michelle C Johansen; Michelle Lin; Saman Nazarian; Rebecca F Gottesman
Journal:  Neurology       Date:  2019-01-23       Impact factor: 9.910

6.  Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study.

Authors:  Shadi Yaghi; Amelia K Boehme; Rebecca Hazan; Eldad A Hod; Alberto Canaan; Howard F Andrews; Hooman Kamel; Randolph S Marshall; Mitchell S V Elkind
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-10-21       Impact factor: 2.136

Review 7.  Atrial Fibrillation Monitoring in Cryptogenic Stroke: the Gaps Between Evidence and Practice.

Authors:  Krittapoom Akrawinthawong; Karthik Venkatesh Prasad; Ali Akbar Mehdirad; Scott Wayne Ferreira
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 8.  Anticoagulation Resumption After Stroke from Atrial Fibrillation.

Authors:  Brian Mac Grory; Shane Flood; Matthew Schrag; Maurizio Paciaroni; Shadi Yaghi
Journal:  Curr Atheroscler Rep       Date:  2019-05-20       Impact factor: 5.113

Review 9.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

Review 10.  Paroxysmal Atrial Fibrillation: Novel Strategies for Monitoring and Implications for Treatment in Stroke.

Authors:  Scott B Silverman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.